---
figid: PMC6859340__DMSO-12-2325-g0007
figtitle: Mechanism of Cdc42/Wnt/Beta-catenin signaling pathway in ADSC-derived IPCs
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC6859340
filename: DMSO-12-2325-g0007.jpg
figlink: pmc/articles/PMC6859340/figure/F0007/
number: F7
caption: 'The mechanism of Cdc42/Wnt/β-catenin signaling pathway in ADSC-derived IPCs.
  Wnt-3a administration activates Wnt, which combines with LPR5/6 and Fz, and restores
  Dvl2 recruitment. GSK3β goes through phosphorylation to impede β-catenin phosphorylation
  by obstructing the combination of Dvl, GSK3β, Axin, and CK1. As a result, non-p-β-catenin
  escapes ubiquitin-proteasome-dependent degradation and activates TCF7L2 and downstream
  genes (PDX1, Ngn3, NeuroD1, GLUT2, and Insulin) after translocation to the nucleus.
  Eventually, Wnt/β-catenin signaling promotes ADSC-derived IPC development and insulin
  secretion. Cdc42 inhibition by ML141 leads to down-regulation of Wnt/β-catenin signaling.
  Therefore, interaction of Dvl, GSK3β, Axin, and CK1 promotes β-catenin ubiquitin-proteasome-dependent
  phosphorylation and degradation, ending up with inactivated target genes (TCF7L2,
  PDX1, Ngn3, NeuroD1, and GLUT2), thereby inhibiting ADSC-derived IPC development
  and insulin secretion.Abbreviations: Cdc42, cell division cycle protein 42; LPR5/6,
  low-density lipoprotein receptor-associated protein 5/6; Fz, frizzled; GSK3β, glycogen
  synthase kinase 3β; p-GSK3β, phosphorylated glycogen synthase kinase 3β; Dvl, dishevelled;
  CK1, casein kinase 1; non-p-β-catenin, unphosphorylated β-catenin; TCF7L2, transcription
  factor 7-like 2; PDX1, pancreatic and duodenal homeobox 1; Ngn3, neurogenin 3; NeuroD1,
  neurogenic differentiation 1; GLUT2, glucose transporter 2; ADSCs, adipose-derived
  mesenchymal stem cells; IPCs, insulin-producing cells.'
papertitle: Cdc42 Promotes ADSC-Derived IPC Induction, Proliferation, And Insulin
  Secretion Via Wnt/β-Catenin Signaling.
reftext: Xing-Hua Xiao, et al. Diabetes Metab Syndr Obes. 2019;12:2325-2339.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9631824
figid_alias: PMC6859340__F7
figtype: Figure
redirect_from: /figures/PMC6859340__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6859340__DMSO-12-2325-g0007.html
  '@type': Dataset
  description: 'The mechanism of Cdc42/Wnt/β-catenin signaling pathway in ADSC-derived
    IPCs. Wnt-3a administration activates Wnt, which combines with LPR5/6 and Fz,
    and restores Dvl2 recruitment. GSK3β goes through phosphorylation to impede β-catenin
    phosphorylation by obstructing the combination of Dvl, GSK3β, Axin, and CK1. As
    a result, non-p-β-catenin escapes ubiquitin-proteasome-dependent degradation and
    activates TCF7L2 and downstream genes (PDX1, Ngn3, NeuroD1, GLUT2, and Insulin)
    after translocation to the nucleus. Eventually, Wnt/β-catenin signaling promotes
    ADSC-derived IPC development and insulin secretion. Cdc42 inhibition by ML141
    leads to down-regulation of Wnt/β-catenin signaling. Therefore, interaction of
    Dvl, GSK3β, Axin, and CK1 promotes β-catenin ubiquitin-proteasome-dependent phosphorylation
    and degradation, ending up with inactivated target genes (TCF7L2, PDX1, Ngn3,
    NeuroD1, and GLUT2), thereby inhibiting ADSC-derived IPC development and insulin
    secretion.Abbreviations: Cdc42, cell division cycle protein 42; LPR5/6, low-density
    lipoprotein receptor-associated protein 5/6; Fz, frizzled; GSK3β, glycogen synthase
    kinase 3β; p-GSK3β, phosphorylated glycogen synthase kinase 3β; Dvl, dishevelled;
    CK1, casein kinase 1; non-p-β-catenin, unphosphorylated β-catenin; TCF7L2, transcription
    factor 7-like 2; PDX1, pancreatic and duodenal homeobox 1; Ngn3, neurogenin 3;
    NeuroD1, neurogenic differentiation 1; GLUT2, glucose transporter 2; ADSCs, adipose-derived
    mesenchymal stem cells; IPCs, insulin-producing cells.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT3A
  - CDC42
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - CTNNB1
  - SLC2A2
  - TCF7L2
  - NEUROG3
  - PDX1
  - PDHX
  - TLE4
  - TFF1
  - NEUROD1
  - wnt3a
  - cdc42
  - cdc42l
  - apc
  - ctnnb1
  - slc2a2
  - tcf7l2
  - neurog3
  - pdx1
  - neurod1
---
